Aug 22, 2023
Palovarotene
Palovarotene Sohonos CAS 410528-02-8 4-[(E)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic acid FDA 8/16/2023 To reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva RG-667 RO-3300074 Palovarotene, sold…
View On WordPress